Amit Nathwani

3.4k total citations
67 papers, 1.5k citations indexed

About

Amit Nathwani is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Amit Nathwani has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Genetics and 20 papers in Oncology. Recurrent topics in Amit Nathwani's work include CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Amit Nathwani is often cited by papers focused on CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Amit Nathwani collaborates with scholars based in United Kingdom, United States and France. Amit Nathwani's co-authors include Andrew M. Davidoff, Catherine Y. Ng, Christian J. Streck, Arnold Pizzey, Kwee Yong, Edward G. D. Tuddenham, Junfang Zhou, Chara Kyriakou, Neil Rabin and Youbin Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Amit Nathwani

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amit Nathwani United Kingdom 24 601 429 311 302 246 67 1.5k
Kirsten van Lom Netherlands 25 539 0.9× 427 1.0× 253 0.8× 326 1.1× 579 2.4× 47 1.5k
André Gothot Belgium 22 559 0.9× 468 1.1× 469 1.5× 360 1.2× 696 2.8× 69 1.9k
Nina S. Funa Sweden 21 761 1.3× 290 0.7× 340 1.1× 518 1.7× 144 0.6× 42 2.0k
Li Gao China 20 359 0.6× 314 0.7× 341 1.1× 617 2.0× 483 2.0× 87 1.4k
Juehua Gao United States 16 339 0.6× 269 0.6× 233 0.7× 253 0.8× 197 0.8× 60 1.1k
Mathias Schmid Germany 24 704 1.2× 638 1.5× 233 0.7× 383 1.3× 807 3.3× 86 2.0k
Takashi Taga Japan 20 637 1.1× 279 0.7× 160 0.5× 220 0.7× 675 2.7× 114 1.5k
Sandrine Bouchet France 16 448 0.7× 994 2.3× 292 0.9× 308 1.0× 246 1.0× 31 1.7k
Laura Porretti Italy 27 840 1.4× 472 1.1× 275 0.9× 219 0.7× 353 1.4× 72 2.1k
Elisa Rossi Italy 25 581 1.0× 255 0.6× 206 0.7× 546 1.8× 111 0.5× 78 1.8k

Countries citing papers authored by Amit Nathwani

Since Specialization
Citations

This map shows the geographic impact of Amit Nathwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Nathwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Nathwani more than expected).

Fields of papers citing papers by Amit Nathwani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Nathwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Nathwani. The network helps show where Amit Nathwani may publish in the future.

Co-authorship network of co-authors of Amit Nathwani

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Nathwani. A scholar is included among the top collaborators of Amit Nathwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Nathwani. Amit Nathwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muczynski, Vincent, Olivier D. Christophe, Alain P. Guérin, et al.. (2025). Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibody. Blood. 146(26). 3175–3187.
2.
Nathwani, Amit, John G. Gribben, Sergey Krysov, et al.. (2024). MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL. Leukemia Research. 143. 107540–107540. 2 indexed citations
3.
Nathwani, Amit, et al.. (2024). 10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer. Frontiers in Oncology. 14. 1429330–1429330. 3 indexed citations
4.
Nathwani, Amit, et al.. (2023). Mathematical modelling of gene delivery in patients with haemophilia B. Chemical Engineering Science. 281. 119073–119073. 1 indexed citations
5.
Delignat, Sandrine, Maxime Lecerf, Rémi Noé, et al.. (2023). Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy. Journal of Thrombosis and Haemostasis. 21(9). 2405–2417. 5 indexed citations
6.
Peyron, Ivan, Olivier D. Christophe, Charlotte Kawecki, et al.. (2020). A hemophilia A mouse model for the in vivo assessment of emicizumab function. Blood. 136(6). 740–748. 44 indexed citations
7.
Kia, Azadeh, et al.. (2019). Liver-directed gene therapy corrects Fabry disease in mice. Molecular Genetics and Metabolism. 126(2). S80–S80. 8 indexed citations
8.
Foley, Jonathan H., Jenny McIntosh, Romuald Corbau, et al.. (2018). A Novel Lysine to Arginine Substitution at Position 301 Enhances Activity of Factor IX. Blood. 132(Supplement 1). 3772–3772. 1 indexed citations
9.
Yang, Chengtao, Anna French, Pollyanna Goh, et al.. (2014). Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co‐express gamma and beta globins. British Journal of Haematology. 166(3). 435–448. 25 indexed citations
10.
Theodoulou, Annika, et al.. (2012). Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia. Transfusion and Apheresis Science. 46(2). 159–162. 22 indexed citations
11.
Tracey, Lorraine, Christian J. Streck, Zhenhua Du, et al.. (2010). NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia. Leukemia. 24(4). 806–812. 14 indexed citations
12.
Hamner, John B., Regan F. Williams, Shannon F. Rosati, et al.. (2010). Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1537–1545. 109 indexed citations
13.
Lydyard, Peter M., Amit Nathwani, Vincent C. Emery, et al.. (2009). Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4+ perforin expressing T cells enriched for human cytomegalovirus specificity and an effector‐memory phenotype. British Journal of Haematology. 148(2). 274–284. 11 indexed citations
14.
Kyriakou, Chara, Neil Rabin, Arnold Pizzey, Amit Nathwani, & Kwee Yong. (2008). Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica. 93(10). 1457–1465. 108 indexed citations
15.
Streck, Christian J., Paxton V. Dickson, Catherine Y. Ng, et al.. (2005). Adeno-Associated Virus Vector-Mediated Systemic Delivery of IFN-β Combined with Low-Dose Cyclophosphamide Affects Tumor Regression in Murine Neuroblastoma Models. Clinical Cancer Research. 11(16). 6020–6029. 38 indexed citations
16.
Streck, Christian J., Catherine Y. Ng, Youbin Zhang, et al.. (2005). Interferon-mediated anti-angiogenic therapy for neuroblastoma. Cancer Letters. 228(1-2). 163–170. 22 indexed citations
17.
Davidoff, Andrew M., Catherine Y. Ng, Youbin Zhang, et al.. (2004). Careful Decoy Receptor Titering is Required to Inhibit Tumor Angiogenesis While Avoiding Adversely Altering VEGF Bioavailability. Molecular Therapy. 11(2). 300–310. 16 indexed citations
18.
Streck, Christian J., Junfang Zhou, Catherine Y. Ng, et al.. (2004). Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma1. Journal of the American College of Surgeons. 199(1). 78–86. 13 indexed citations
19.
Folarin, Najeem, Robert J. Baker, Veronique Duke, et al.. (2004). Zap-70 and IgVH Mutation Status in Combination with p53 Functional Analysis Identifies the Response of Poor Prognosis B-CLL Patients to Conventional Cytotoxic Agents.. Blood. 104(11). 1907–1907. 1 indexed citations
20.
Forbes, Louisa V., Rosemary E. Gale, Arnold Pizzey, et al.. (2002). An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. Oncogene. 21(39). 5981–5989. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsten van Lom Breakdown of academic impact, for papers by André Gothot Breakdown of academic impact, for papers by Nina S. Funa Breakdown of academic impact, for papers by Li Gao Breakdown of academic impact, for papers by Juehua Gao Breakdown of academic impact, for papers by Mathias Schmid Breakdown of academic impact, for papers by Takashi Taga Breakdown of academic impact, for papers by Sandrine Bouchet Breakdown of academic impact, for papers by Laura Porretti Breakdown of academic impact, for papers by Elisa Rossi
Rankless by CCL
2026